Memorial Sloan-Kettering Cancer Center

Advocacy Academy participants: Mesias Pedroza, PhD, Baylor College of Medicine; Chloe N. Poston, PhD, Eli Lilly and Company; Jeffery G. Mellott, PhD Northeast Ohio Medical University Last week, we held our inaugural Advocacy Academy, bringing 12 postdoctoral researchers from across the U.S. to Washington, D.C. A two-day advocacy training program that culminated in Congressional visits with the participants’€™ representatives. We selected this group of motivated and concerned early-career scientists from a diversity of institutions, including Northeast Ohio Medical University, UCSF, Memorial Sloan-Kettering Cancer Center, Baylor College of Medicine, the University of Pennsylvania School of...
Advocacy Academy participants: Mesias Pedroza, PhD, Baylor College of Medicine; Chloe N. Poston, PhD, Eli Lilly and Company; Jeffery G. Mellott, PhD Northeast Ohio Medical University Last week, we held our inaugural Advocacy Academy, bringing 12 postdoctoral researchers from across the U.S. to Washington, D.C. A two-day advocacy training program that culminated in Congressional visits with the participants’€™ representatives. We selected this group of motivated and concerned early-career scientists from a diversity of institutions, including Northeast Ohio Medical University, UCSF, Memorial Sloan-Kettering Cancer Center, Baylor College of Medicine, the University of Pennsylvania School of...
Excerpt of an op-ed by columnist George F. Will, published in The Washington Post. ’€œThe capacity to blunder slightly is the real marvel of DNA. Without this special attribute, we would still be anaerobic bacteria and there would be no music.’€ ’€” Lewis Thomas The pedigree of human beings, Thomas wrote, probably traces to a single cell fertilized by a lightning bolt as the Earth was cooling. Fortunately, genetic ’€œmistakes’€ ’€” mutations ’€” eventually made us. But they also have made illnesses. Almost all diseases arise from some combination of environmental exposures and genetic blunders in the working of DNA. Breast cancer is a family of genetic mutations. The great secret of...
Excerpt of an op-ed by columnist George F. Will, published in The Washington Post. ’€œThe capacity to blunder slightly is the real marvel of DNA. Without this special attribute, we would still be anaerobic bacteria and there would be no music.’€ ’€” Lewis Thomas The pedigree of human beings, Thomas wrote, probably traces to a single cell fertilized by a lightning bolt as the Earth was cooling. Fortunately, genetic ’€œmistakes’€ ’€” mutations ’€” eventually made us. But they also have made illnesses. Almost all diseases arise from some combination of environmental exposures and genetic blunders in the working of DNA. Breast cancer is a family of genetic mutations. The great secret of...
Research saves lives. Fundamental research into pediatric cancers has led to a 66% decrease in mortality for these cancers over the past 40 years. Research!America is proud to recognize May as National Cancer Research Month in conjunction with our many members who are working to find and fund cures for all types of cancer. Research institutions like the Dana-Farber Cancer Institute , Fred Hutchinson Cancer Research Center , University of Texas MD Anderson Cancer Center and Memorial Sloan-Kettering Cancer Center are just a handful of Research!America members who are working in this vital area of research. In light of the ongoing debates among Washington policy makers about priorities for the...
Large medical centers across the U.S. are investing in a burgeoning area of healthcare for their cancer patients: €œprecision medicine. Substantial investments are being made to not only build new laboratory facilities and purchase research equipment, but also to staff these new facilities. Universities like Weill Cornell Medical College , Harvard Medical School , and Johns Hopkins University are joining clinical centers like Memorial Sloan-Kettering Cancer Center in building an infrastructure for personalized medicine with the hope of playing a bigger role in the development of new drugs. This approach is building off of years of federal investment in genomics research. First, the Human...
Scientists at Memorial Sloan-Kettering Cancer Center , a Research!America member, have successfully treated a handful of leukemia patients with cutting-edge immune cell therapy. This therapy, similar to previous trials at the University of Pennsylvania and the National Cancer Institute, modifies the patient’€™s immune cells so that they recognize and kill the cancer cells. This experimental therapy provides a new avenue of treatment for patients who have undergone all of the traditional treatments like chemotherapy without achieving remission of the cancer. Read more about this exciting breakthrough in this New York Times article . The study’€™s senior author, Michael Sadelain, MD, PhD,...